Skip to search formSkip to main contentSkip to account menu

Calusterone

Known as: 7-beta,17-Dimethyltestosterone, Androst-4-en-3-one, 17.beta.-hydroxy-7.beta.,17-dimethyl- (8CI), Androst-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7.beta., 17.beta.)- (9CI) 
A 17-alkylated orally active androgenic steroid. Calusterone may alter the metabolism of estradiol and reduce estrogen production. (NCI04)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1983
1983
Microsomal epoxide hydrolase, a major antigenic marker of putative preneoplastic hepatocytes was studied in hyperplastic liver… 
1981
1981
Studies were undertaken in mice to determine the effect of calusterone (a weakly androgenic steroid) on hemopoiesis. Animals were… 
1979
1979
Die vorliegende Arbeit berichtet uber klinische Untersuchungen am Krebszentrum der Universitat von Arizona zur Verbesserung der… 
1977
1977
Calusterone was given at a dose of 200 mg daily to 45 postmenopausal patients with advanced metastatic breast cancer. Of the 40… 
1977
1977
Calusterone® (7β, 17α-dimethyltestosterone) is a 17-alkylated, orally active androgenic steroid used in the treatment of breast… 
1970
1970
Twenty-two women with far advanced, hormone-refractory breast cancer were treated with 7β,17α dimethyltestosterone (calusterone… 
1970
1970
Twenty-two women with far advanced, hormone-refractory breast cancer were treated with 7beta,17alpha dimethyltestosterone…